Therapeutic Advances in Endocrinology and Metabolism内分泌与代谢治疗进展
Therapeutic Advances in Endocrinology and Metabolism(英文缩写 THER ADV ENDOCRINOL),ISSN 2042-0188,eISSN 2042-0196,中文译名:内分泌与代谢治疗进展 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-24 至 2026-09-24，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 4.435 | Q2 |
| 2022 | 3.800 | Q2 |
| 2023 | 3.900 | Q2 |
| 2024 | 4.600 | Q1 |
| 2025 | 7.800 | Q1 |
Therapeutic Advances in Endocrinology and Metabolism 最新收录文献
-
1. Assessing the quality and reliability of health information on GLP-1 receptor agonists on TikTok and Bilibili: a cross-sectional analysis of the public health infodemic.
PMID:日期:2026-01-01Glucagon-like peptide-1 (GLP-1) receptor agonists have transitioned from clinical tools for diabetes to a global cultural phenomenon for weight loss, triggering an "infodemic." While previous studies …
-
2. Association between the ratio of uric acid to high-density lipoprotein cholesterol (UHR) and the abnormal risk of sarcopenia: Evidence from two large population-based surveys and interpretable machine learning-driven sarcopenia screening.
PMID:日期:2026-01-01Sarcopenia is a geriatric syndrome linked to nutritional intake, chronic inflammation and metabolic dysregulation. While uric acid (UA) and high-density lipoprotein cholesterol (HDL-C) are recognized …
-
3. Glucose-lowering therapy in diabetes of the exocrine pancreas: a real-world evidence analysis in a tertiary hospital in the timeframe 2018-2022.
PMID:日期:2026-01-01Diabetes of the exocrine pancreas (DEP) is a form of diabetes that arises in the presence of an exocrine pancreas disease and is mainly associated with acute and chronic pancreatitis. Therapeutic mana…
-
4. Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology.
PMID:日期:2026-01-01Insulin resistance is a common metabolic feature of metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes (T2D), but its cross-sectional association with the coexistence…
-
5. Association between glycerol triglyceride glucose-related index and cardiovascular disease in individuals with metabolic dysfunction-associated steatotic liver disease: NHANES 1999-2023.
PMID:日期:2026-01-01Cardiovascular disease (CVD) is more common in those with metabolic dysfunction-associated steatotic liver disease (MASLD). Although the triglyceride-glucose index (TyG) and its composite indices are …
-
6. A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design.
PMID:日期:2026-01-01Hypochondroplasia is a skeletal dysplasia characterized by disproportionate short stature that is caused by gain-of-function variants in the fibroblast growth factor receptor 3 gene (), which negative…
-
7. Iodine concentrations in human milk after maternal high therapeutic potassium iodide dosing during breastfeeding: a contribution from the ConcePTION project.
PMID:日期:2026-01-01Iodine is an essential element of human milk. However, high therapeutic maternal doses of potassium iodide (KI) during breastfeeding and its effect on the infant have been insufficiently studied. Ther…
-
8. GLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for people with type 2 diabetes and inflammatory bowel disease.
PMID:日期:2026-01-01Obesity and type 2 diabetes now coexist with IBD. Beyond glucose and weight effects, GLP-1 receptor agonists reduce MACE and lower systemic inflammatory biomarkers. Observational IBD data suggest acce…
-
10. Unrecognized primary aldosteronism may confound outcomes in adrenal Cushing's syndrome.
PMID:日期:2026-01-01Patients with adrenal Cushing's syndrome may also have undiagnosed primary aldosteronism-a condition that causes high blood pressure and low potassium. Both hormone problems can arise from the same ad…